Response to letter entitled: Re: Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? An international multicenter analysis

Eur J Cancer. 2021 Jul:152:257-258. doi: 10.1016/j.ejca.2021.05.002. Epub 2021 Jun 8.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Chemotherapy, Adjuvant
  • Female
  • Humans
  • Ovarian Neoplasms* / drug therapy
  • Teratoma* / drug therapy